SCHEMBL5422162

SCHEMBL5422162

CN(C)c1nc(Nc2ccc(Cl)c(Cl)c2)ncc1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.45
PIK3CB P42338 1/20 0.45
PIK3CG P48736 1/20 0.45
BRD4 O60885 1/20 0.45
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
MAPT P10636 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MCL1 Q07820 1/20 0.45
PTK2B Q14289 1/20 0.45
GSK3B P49841 2/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
STK17A Q9UEE5 3/20 0.43
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5425855 0.86 STK17A (0.56) PIK3CAPIK3CBPIK3CGBRD4MEN1
SCHEMBL5410032 0.82 GSK3B (0.54) PIK3CAPIK3CBPIK3CGBRD4MEN1
SCHEMBL5424169 0.81 STK17A (0.48) GSK3BHDAC3HDAC1HDAC2HDAC6
SCHEMBL3288525 0.79 STK17A (0.57) BRD4MEN1KMT2AMAPTCYP1A2
SCHEMBL5424126 0.79 GSK3B (0.51) PIK3CAPIK3CBPIK3CGBRD4MEN1
SCHEMBL5414085 0.79 STK17A (0.56) PIK3CAPIK3CBPIK3CGBRD4MEN1
SCHEMBL1916444 0.78 STK17A (0.60) BRD4MEN1KMT2AMAPTCYP1A2
SCHEMBL5413815 0.78 BRD4 (0.53) PIK3CAPIK3CBPIK3CGBRD4MEN1
SCHEMBL1918649 0.77 STK17A (0.59) BRD4MEN1KMT2AMAPTCYP1A2
SCHEMBL5416081 0.76 STK17A (0.61) BRD4MEN1KMT2AMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166599-B2 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-01-23 US disclosed
US-20050090486-A1 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-04-28 US disclosed
US-20030134838-A1 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134838-A1 Trisubstituted pyrimidines APP, PSEN1, BACE1 PIK3CA 2423/4885PIK3CB 3445/4885PIK3CG 3478/4885
US-20050090486-A1 Trisubstituted pyrimidines APP, BACE1, PSEN1 PIK3CA 2145/4885PIK3CB 3431/4885PIK3CG 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.